Cargando…
A luciferase based automated assay for rapid and sensitive detection of SARS-CoV-2 antibodies
The Coronavirus disease 2019 (COVID-19) pandemic brings great challenges to the public health and social economics around the world. As the pandemic continues and the mass vaccination goes on, monitoring the antibodies is particularly important for the epidemiological survey and vaccine assessment....
Autores principales: | Zhou, Wenhao, He, Ping, Liu, Huan, Wei, Hongping, Yu, Junping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672313/ https://www.ncbi.nlm.nih.gov/pubmed/36464447 http://dx.doi.org/10.1016/j.aca.2022.340633 |
Ejemplares similares
-
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
por: Yao, Zhong, et al.
Publicado: (2021) -
A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein
por: Liang, Yuanhao, et al.
Publicado: (2021) -
Luciferase Immunoprecipitation System Assay, a Rapid, Simple, Quantitative, and Highly Sensitive Antibody Detection for Parasitic Diseases
por: SHABANI AZIM, Faezeh, et al.
Publicado: (2016) -
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
por: Chen, K.Y., et al.
Publicado: (2022) -
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors
por: Chen, KY, et al.
Publicado: (2021)